Clinical trial
Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine…
NCT00096070 · National Cancer Institute (NCI), NIH · Completed
Key facts
| NCT number | NCT00096070 |
|---|---|
| Title | Radiotherapy Combined With Oxaliplatin and Fluorouracil Followed By Gemcitabine in Treating Patients With Locally Advanced, Unresectable Pancreatic Cancer |
| Official title | Phase II Study of Oxaliplatin, Continuous 5-Fluorouracil and External Beam Radiation Followed by Gemcitabine in Patients With Locally Advanced Pancreatic Cancer |
| Lead sponsor | National Cancer Institute (NCI), NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Adenocarcinoma of the Pancreas, Stage II Pancreatic Cancer, Stage III Pancreatic Cancer |
| Intervention type | Drug, Radiation |
| Interventions | radiation therapy, oxaliplatin, fluorouracil, gemcitabine hydrochloride |
| Enrollment | 50 |
| Start date | Dec 1, 2004 |
| Primary completion | Apr 1, 2007 |
| First posted | Nov 9, 2004 |
| Last update posted | Jul 16, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: